A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF)

Clinical trial NCT01025713 · WITHDRAWN

Trial details

NCT number: NCT01025713
Sponsor: Gilead Sciences
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis Mucociliary Clearance

Start date: 2009-12-01
Primary completion: 2010-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.